Recurrent takotsubo syndrome in a patient with myotonic dystrophy 1

References

• Neil CJ, Nguyen TH, Sverdlov AL, Chirkov YY, Chong CR, Stansborough J, et al. Can we make sense of takotsubo cardiomyopathy? An update on pathogenesis, diagnosis and natural history. Expert Rev Cardiovasc Ther. 2012;10:215–21.
   Google Scholar
• Bridgman PG, Chan CW, Elliott JM. A case of recurrent earthquake stress cardiomyopathy with a differing wall motion abnormality. Echocardiography 2012;29:E26–7.
   Google Scholar
• Gach O, Lempereur M, Pierard LA, Lancellotti P. Recurrent stress cardiomyopathy with variable pattern of left ventricle contraction abnormality. J Am Coll Cardiol. 2012;60:e5.
   Google Scholar
• Kaushik M, Alla VM, Madan R, Arouni AJ, Mohiuddin SM. Recurrent stress cardiomyopathy with variable regional involvement: insights into etiopathogenetic mechanisms. Circulation 2011;124:e556–7.
   PubMed Web of Science ®Google Scholar
• Kubiak G, Jacheć W, Kawecki D, Traczewska M, Irlik G, Nowalany-Kozielska E. Tako-tsubo cardiomyopathy as a recurrent disease with doubtful prognosis of recovery and heterogenic symptoms. Cardiol J. 2012;19:521–3.
   Google Scholar
• Tait J, Cleveland D, Ashton T. Unusual reversed wall motion pattern in a patient with recurrent takotsubo cardiomyopathy. Can J Cardiol. 2013;29:1015.e13-4.
   Google Scholar
• Zlotnick DM, Helisch A. Recurrent stress cardiomyopathy induced by Sudafed PE. Ann Intern Med. 2012;156:171–2.
   Google Scholar
• Petri H, Vissing J, Witting N, Bundgaard H, Køber L. Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol. 2012;160:82–8.
   Google Scholar
• Nazarian S, Wagner KR, Caffo BS, Tomaselli GF. Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy. Pacing Clin Electrophysiol. 2011;34:171–6.
   Google Scholar
• Facenda-Lorenzo M, Hernández-Afonso J, Rodríguez-Esteban M, de León-Hernández JC, Grillo-Pérez JJ. Cardiac manifestations in myotonic dystrophy type 1 patients followed using a standard protocol in a specialized unit. Rev Esp Cardiol. 2013;66:193–7.
   Google Scholar
• Nakada T, Yonesaka S. ‘Hypertrophic cardiomyopathy’ in a girl with adult-type myotonic dystrophy. Pediatr Int. 1999;41:586–8.
   PubMed Web of Science ®Google Scholar
• Gunkel O, Reichenbach H, Thamm B, Wetzel U, Bratanow S, Kirchhof M, et al. Late diagnosis of Curschmann-Steinert myotonic dystrophy in a female patient with dilated cardiomyopathy and in her son. Z Kardiol. 2000;89:599–605.
   Google Scholar
• Finsterer J, Stölberger C, Kopsa W. Noncompaction in myotonic dystrophy type 1 on cardiac MRI. Cardiology 2005;103:167–8.
   PubMed Web of Science ®Google Scholar
• Finsterer J, Stöllberger C, Avanzini M, Prager E, Weidinger F. Asymptomatic, nonsustained ventricular tachycardia in myotonic dystrophy type 1 detected with a loop recorder. Eur Neurol. 2008;60:109–11.
   Google Scholar
• Porto I, Della Bona R, Leo A, Proietti R, Pieroni M, Caltagirone C, et al. Stress cardiomyopathy (tako-tsubo) triggered by nervous system diseases: A systematic review of the reported cases. Int J Cardiol 2013;167:2441–8.
   Google Scholar
• Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina pectoris – myocardial Infarction Investigations in Japan. J Am Coll Cardiol. 2001;38:11–8.
   PubMed Web of Science ®Google Scholar
• Bortnik M, Verdoia M, Schaffer A, Occhetta E, Marino P. Ventricular fibrillation as primary presentation of takotsubo cardiomyopathy after complicated cesarean delivery. World J Cardiol. 2012;4:214–7.
   Google Scholar
• Amariles P. A comprehensive literature search: Drugs as possible triggers of Takotsubo cardiomyopathy. Curr Clin Pharmacol. 2011;6:1–11.
   PubMedGoogle Scholar
• Osuorji I, Williams C, Hessney J, Patel T, Hsi D. Acute stress cardiomyopathy following treatment of status asthmaticus. South Med J. 2009;102:301–3.
   PubMed Web of Science ®Google Scholar
• McAdow M, Kim HK, Dedent AC, Hendrickx AP, Schneewind O, Missiakas DM. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog. 2011;7:e1002307. doi:10.1371/journal.ppat.1002307.
   PubMed Web of Science ®Google Scholar
• Gill SK, Theodorides A, Smith N, Maguire E, Whitehouse SL, Rigby MC, et al. Wound problems following hip arthroplasty before and after the introduction of a direct thrombin inhibitor for thromboprophylaxis. Hip Int. 2011;21:678–83.
   PubMedGoogle Scholar
• Kaminsky P, Lesesve JF, Jonveaux P, Pruna L. IgG deficiency and expansion of CTG repeats in myotonic dystrophy. Clin Neurol Neurosurg. 2011;113:464–8.
   Google Scholar